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Background: In past two decades, health expenditure in China grew at a rate of 11.6% per year, which is much
faster than the growth of the country’s economy (9.9% per year). As cost containment is a key aspect of China’s
new health system reform agenda, this study aims to identify the main drivers of past growth so that cost
containment policies are focussed in the right areas.
Method: The analysis covered the period 1993–2012. To understand the drivers of past growth during this period, Das
Gupta’s decomposition method was used to decompose the changes in health expenditure by disease into five main
components that include population growth, population ageing, disease prevalence rate, expenditure per case of
disease, and excess health price inflation. Demographic data on population size and age-composition were obtained
from the Department of Economic and Social Affairs of the United Nations. Age- and disease- specific expenditure and
prevalence rates by age and disease were extracted from China’s National Health Accounts studies and Global Burden
of Disease 2013 studies of the Institute for Health Metrics and Evaluation, respectively.
Results: Growth in health expenditure in China was mainly driven by a rapid increase in real expenditure per prevalent
case, which contributed 8.4 percentage points of the 11.6% annual average growth. Excess health price inflation and
population growth contributed 1.3 and 1.3% respectively. The effect of population ageing was relatively small, contributing
0.8% per year. However, reductions in disease prevalence rates reduced the growth rate by 0.3 percentage points.
Conclusion: Future policy in optimising growth in health expenditure in China should address growth in
expenditure per prevalent case. This is especially so for neoplasms, and for circulatory and respiratory disease.
And a focus on effective interventions to reduce the prevalence of disease in the country will ensure that
changing disease rates do not lead to a higher growth in future health expenditure; Measures should be
taken to strengthen the capacity of health personnel in grass-roots facilities and to establish an effective
referral system, so as to reduce the growth in expenditure per case of disease and to ensure that excess
health price inflation does not grow out of control.
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This study aims to identify each driver’s contribution to
health expenditure growth in the past at the disease level
to identify the main drivers of past growth. This enables
the government to identify areas where future savings can
be realised. The resulting estimates can also be useful for
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Total health expenditure in China has grown consider-
ably since economic reform started in 1978. Between
1978 and 2012 total health expenditure in China grew at
a rate of 11.7% per annum, which is higher than that of
gross domestic product (GDP) (9.9%), leading to an in-
crease in the health expenditure share of GDP from 3.0
to 5.3% during the same period. The growth in health
spending has been particularly rapid since the new
round of health system reform was enacted in 2009
(13.1% annual average growth in the period 2009 to
2012). Since 2009 the income elasticity of health carele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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cost of health care is a key focus of China’s new round
of health system reform, with cost containment in public
hospitals being a core aspect of the government agenda
[2]. In this respect, understanding the main drivers of
past health spending growth is important because, by
identifying the main factors responsible for past growth,
it enables the government to identify areas where future
savings can be realised. The resulting estimates can
also be useful for planning the future of the health
care system in China. In the past, statistical methods
were mainly used to identify the drivers of health ex-
penditure growth. Regression methods, such as princi-
pal component regression, dynamic model and ridge
regression analysis that have been used to analyse the
drivers of aggregated total or regional health expend-
iture in China, have found that population ageing, in-
come level and urbanisation were the main drivers
[3–5]. However, their estimation of each factor’s con-
tribution to health expenditure growth was not con-
sistent, and some important drivers of health
expenditure growth were not included, such as dis-
ease prevalence rates or health price inflation [3–5].
Previous studies did not identify the relative contribu-
tion of each factor to the growth of disease-specific
expenditure. Fully allocating disease-specific expend-
iture growth into the main policy relevant drivers can
offer detailed information for policy-making.
To our knowledge, this is the first study to compre-
hensively examine the policy-relevant drivers of health
expenditure by disease in China, and identify the relative
contribution of each factor to the growth of disease-
specific expenditure in the past 20 years. The aim of this
study is to decompose the main drivers of China’s health
expenditure growth, with a special focus on the effects
of changes in the disease prevalence rate, population
size, population ageing, real expenditure per case of
disease and excess health price inflation (EHPI).
Methods
Study design
Regression methods are commonly used to identify the
main factors affecting health expenditure growth over
time or across countries [6–10]. Specifically, the residual
method is commonly used. This identifies a series of fac-
tors such as general inflation, population ageing, the
spread of insurance and rising income that contribute to
health expenditure growth; determines how much of the
change they might account for; and attributes the
residual to technological advances [11]. This method,
however, may lead to an overestimate of the effect of
technological progress if all of the residual is attributed
to technological advances and other unobserved factors
besides technology may be in the residual [12]. Residualmethods use historical time series data to ensure a pre-
cise decomposition of growth of health expenditure [13].
Another approach can be used for decomposing the
effect of different factors on health expenditure growth
is the Das Gupta decomposition method [14, 15], which
needs two time points of data only. This method is
widely used in demographic and health studies [16, 17].
Das Gupta’s decomposition method decomposes the dif-
ference between two quantities (rates, means, propor-
tions, ratios, or absolute values, etc.) into additive
components (Additional file 1). This method develops
several counterfactual scenarios and calculates the effect
of each factor on changes from the present level assum-
ing that all other factors, except the factor under consid-
eration, remains the same during the study period. This
method gives results that are independent of the order
in which the factors are considered. In addition, instead
of having a separate interaction component, Das Gupta’s
decomposition method distributes interaction effects in
proportion to the strength of each of the main effects.
This distribution does not change conclusions about the
relative importance of the factors. It only simplifies the
picture [15]. In this study, we developed a model based
on Das Gupta’s decomposition method to decompose
the main drivers of health expenditure growth in China.
The model
The health expenditure decomposed in this study is
current health expenditure, which means capital forma-
tion is not included. Factors influencing health spending
include demand-side factors, such as ageing and the
health status of a population, income growth, and con-
sumer behaviour; supply-side drivers, such as techno-
logical progress and changes in treatment practices,
productivity, and health prices; and regulatory factors,
such as institutional characteristics of health systems
and their financing [18].
Considering the availability of data, practical possibil-
ities and interrelationships among the factors, the demo-
graphic factors include population growth and
population ageing and the non-demographic factors in-
clude disease prevalence rate, expenditure per prevalent
case and EHPI was selected in the model. Therefore,
health expenditure in time t can be expressed as the
product of these factors:
Et ¼
Xn
i¼1
Xm
j¼1
Popt  Sijt  Rijt  RE per caseijt  Iijt
where i represents disease group, j represents age group.
Et represents health expenditure in time t, Popt is the
total population at time t, Sjt is the share of population
of disease i in age group j at time t, Rijt is the prevalence
rate of disease i in age group j at time t, RE_per caseijt, is
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inafter “expenditure per prevalent case”) of disease i in
age group j at time t, Iijt is the EHPI of disease i in age
group j at time t.
If Eit represents health expenditure on disease i at
time t and EiT represents health expenditure on dis-
ease i at time T, consequently, the difference (Ed) of
health expenditure on disease i at time t and T can
be expressed as:
Ed ¼ EiT−Eit ¼ Population growth effect
þAgeingeffect þ Disease prevalence rate effect
þExpenditure per prevalent case effectþ EHPIeffect
Interaction effects among the five factors can be
distributed across the main effects using Das Gupta’s
decomposition method [19]. 32 counterfactual scenar-
ios were developed by a Das Gupta’s decomposition
Stata module to represent the principal drivers of
changes in health expenditure in China, then different
numbers for health expenditure using the above 32
scenarios were computed, and the net change in these
scenarios is equal to the actual total change of health
expenditure.
We chose 1993 as the base year for our modelling be-
cause in the 1990s health expenditure by age group and
by disease group was only available for 1993 [20]. Also
there was a significant policy change in 1992 when the
government introduced user fees throughout the
country so as to tackle inefficiencies in health service
delivery and meet health demands better [21], so this
made 1993 appropriate as a base year. Data for health
expenditure by age group and by disease group were
next available for 2012 [22], so the year 2012 was
selected as the end date.
Data sources
Population data in 1993 and 2012 were obtained from
the Population Division, Department of Economic and
Social Affairs, United Nations [23]. Population was
divided into eight subgroups in this study: 0–4, 5–9,
10–19, 20–29, 30–39, 40–49, 50–59, 60+, because
disease-specific health expenditure in 1993 could only
be disaggregated into these eight age groups. There-
fore, this analysis cannot reflect differences in the
ageing of the population group 60 years and above.
Disease prevalence rate by age group and disease
group was calculated using prevalent cases by age
group and disease group divided by population by age
group. Disease prevalent case data by age and disease
in 1990, 1995, 2000, 2005, 2010 and 2013 were from
the GBD 2013 Study by the Institute for Health Metrics
and Evaluation (IHME), University of Washington [24].
ICD10 chapters were employed as the diseasecategories in this study. 250 causes from IHME were
coded with ICD10 disease codes according to the List
of International Classification of Disease Codes Mapped
to Global Disease Burden (GBD) Cause List [25].
Chapter XVIII Symptoms, signs and abnormal clinical
and laboratory findings, not elsewhere classified,
chapter XXI Factors influencing health status and con-
tact with health services and chapter XXII Codes for
special purposes are not included, because there is no
cause from IHME which can be allocated against these
three chapters. Chapter XX External causes of morbid-
ity and mortality was grouped into Chapter XIX Injury,
poisoning and certain other consequences of external
causes, as age- and disease-specific health expenditure
data of these two chapters are grouped. Therefore, 18
ICD10 chapters were finally used in this study, which
are consistent with disease categories for health ex-
penditure in 1993 and 2012. The disease prevalence
rate and the annual growth rate of the disease preva-
lence rate were calculated for each of these 18 ICD10
chapters. We calculated the disease prevalence rate by
age and disease in 1993 and 2012 by assuming the an-
nual growth rate of disease prevalence rate by age and
disease between 1990 and 1995 was the same as the
period from 1990 to 1993 and the annual growth rate
of the disease prevalence rate by age and disease be-
tween 2010 and 2013 was the same as the period from
2010 to 2012.
EHPI is a measure of the amount that the change
in prices within the health goods and services sector
of the economy exceeds general inflation [26]. An ag-
gregate health price index was calculated using the
Laspeyres price index method [27]. The EHPI was
1.1% per year during the period 2007 to 2012. We
assumed that EHPI during the period 1993 to 2012
was the same as EHPI from 2007 to 2012; this as-
sumption was necessary as there were no comprehen-
sive reliable data about health price increases for the
period 1993 to 2012. But such data as were available
indicated that EHPI was certainly positive during this
period.
Expenditure per prevalent case of disease i in age
group j was calculated using health expenditure of dis-
ease i in age group j divided by population of age group
j, prevalence rate of disease i in age group j and EHPI.
Therefore, the effect of expenditure per prevalent case
on changes in health expenditure includes what is in
other studies frequently called the residual factor. This
factor includes the impact of technological progress, the
expansion of health insurance and income and the
impact of urbanisation, etc.
Health expenditure estimates by disease group and by
age group in 1993 and 2012 were sourced from the
China National Health Accounts Studies [20, 22].
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To examine the stability of the decomposition results, a
sensitivity analysis was undertaken to gain insight into
the effect in the model of the level of uncertainty with
regard to disease prevalence rates. Therefore, lower and
upper confidence bounds of prevalence rate by age and
disease were calculated using lower and upper bound of
prevalent case by age and disease (with a 95% confidence
interval) divided by population by age group. The mean
of disease prevalence rate by age group refers to the
medium assumptions used in the model. Lower and
upper confidence bounds of prevalence rate from IHME
were used to perform the sensitivity analysis. Scenario 1:
lower value of disease prevalence rate by age group was
adopted; scenario 2: the upper value of disease preva-
lence rate was adopted.
Results
During the period from 1993 to 2012, the population in
China increased from 1203.0 million to 1355.4 million,
and the age structure has changed significantly. The
share of the age groups 0–4, 5–9, 10–19 and 20–29 de-
creased from 10.4%, 9.9%, 16.9% and 20.8% to 6.7%,
6.4%, 14.1% and 19.8%, respectively, while the share of
the age groups 30–39, 40–49, 50–59, 60+ sharply in-
creased from 15.0%, 11.1%, 7.4% and 8.6% to 16.9%,
19.8%, 13.9% and 15.2%, respectively. Figure 1 shows the
changes in age structure in China from 1993 to 2012.
During the same period, the age-standardised disease
prevalence rate decreased from 357.1% (95% CI 302.0–
431.0%) to 304.0% (95% CI 262.4–358.5%). In particular,
the disease prevalence rate of infectious and parasiticFig. 1 The changes in age structure in China from 1993 to 2012diseases decreased from 111.3% (95% CI 84.3–146.8%)
to 64.6% (95% CI 51.4–82.0%), blood-related disease de-
creased from 39.8% (95% CI 38.7–41.5%) to 36.7% (95%
CI 35.5–38.3%), and injury and poisoning decreased
from 8.1% (95% CI 5.8–10.4%) to 6.1% (95% CI 4.5–
8.0%), while the age-standardised prevalence rate of
some diseases increased. For instance, the prevalence
rate for skin diseases increased from 25.3% (95% CI
18.5–37.4%) to 26.6% (95% CI 18.5–38.6%), for endo-
crine, nutritional and metabolic diseases it increased
from 7.3% (95% CI 6.1–8.4%) to 8.2% (95% CI 7.3–9.2%),
for genitourinary diseases it increased from 14.7% (95%
CI 11.6–17.7%) to 15.2% (95% CI 12.6–19.0%), and
respiratory diseases and neoplasms also showed a slight
increase. These trends are consistent with the changes
in age-standardised disease prevalence rates in the
National Household Health Survey Report [28].
Expenditure per prevalent case of each disease in each
age group increased rapidly during the period 1993 to
2012 (Additional file 2).
Real health expenditure increased sharply from 124.5
billion Yuan in 1993 to 1000.6 billion Yuan in 2012 in
constant 1993 prices. The real annual average growth
rate was 11.6% during those two decades. The growth of
health expenditure in China was mainly driven by a
rapid increase in expenditure per case, while the effects
of EHPI and demographic factors were small. On the
other hand, a decline in disease prevalence rates led to
small savings in health expenditure. Figure 2 shows each
factor’s contribution to the growth rate of health ex-
penditure during the period 1993 to 2012. 8.4% of the
growth was caused by the change of real health
Fig. 2 Each factor’s contribution to the growth rate of health
expenditure during the period 1993 to 2012
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ageing and population growth, which contributed 1.3,
1.3 and 0.8%, respectively. Changes in the disease
prevalence rate contributed −0.3% of the growth in
health expenditure in past two decades.
Over the past two decades, health expenditure in
China increased 876.1 billion Yuan in constant 1993
prices. 72.6% of the change was caused by the change in
health expenditure per case, followed by EHPI, popula-
tion ageing and population growth, which contributed
11.6, 11.2 and 6.8%, respectively. On the other hand, a
reduction in disease prevalence rates led to savings of
2.2% (see Fig. 3).Fig. 3 Each factor’s contribution to the difference of health
expenditure during the period 1993 to 2012The changes in expenditure per prevalent case mainly
occurred with circulatory diseases, respiratory diseases,
neoplasms, endocrine, nutritional and metabolic dis-
eases, digestive diseases and injury and poisoning, which
contributed 49.4% of the increase in China’s health
expenditure.
Population ageing affected circulatory diseases the
most, which caused 4.1% of the increase in health ex-
penditure, followed by neoplasms (1.9%), endocrine and
nutrition (1.3%), digestive (1.3%), musculoskeletal dis-
eases (1.0%) and injury, poisoning and other conse-
quences of external causes (0.9%), while ageing alleviated
the growth of health expenditure on certain conditions
originating in the perinatal period (−0.3%), respiratory
disease (−0.2%), maternal disorders (−0.2%) and congeni-
tal malformations (−0.1%).
Population growth and EHPI increased annually 0.6%
and 1.1%, respectively, in the past two decades, which
mainly affected the top six diseases (circulatory, respira-
tory, neoplasms, endocrine, injuries and digestive dis-
eases). The change in the prevalence rate of disease
mostly reduced the growth in health expenditure. For
example, changes in the prevalence rates of injuries, in-
fectious and parasitic diseases and circulatory diseases
alleviated the increase in health expenditure most, which
is −1.6%, −1.4% and −0.8%, respectively. However, for
some diseases the prevalence rate increased and this in-
creased expenditure. The increase in the neoplasm
prevalence rate increased expenditure by 0.8%, the in-
crease in the prevalence rate for endocrine, nutritional
and metabolic diseases increased expenditure by 0.7%,
for maternal disorders expenditure increased by 0.4%,
and for respiratory disease, expenditure increased by
0.2% due to the change in the prevalence rate.
Our results reflect each factor’s contribution to the
change in health expenditure by disease system over the
period from 1993 to 2012. Circulatory diseases, respira-
tory diseases, neoplasms, and endocrine, nutritional and
metabolic diseases and digestive diseases caused 70.5%
of the increase in current health expenditure. Each fac-
tor’s contribution to the change in health expenditure
for each disease was analysed based on the result (see
Table 1). For instance, circulatory disease increased by
181.6 billion Yuan during the period 1993 to 2012,
which accounted for 20.7% of the increase in health ex-
penditure. Sixty-seven percent of the increase in
expenditure on cardiovascular disease was caused by
expenditure per prevalent case, followed by population
ageing, EHPI and population growth, which contributed
19.9, 10.7 and 6.3%, respectively, while the prevalence
rate contributed −3.8%.
Sensitivity analysis showed the decomposition esti-
mates of growth rate and the changes in health
expenditure are robust. Table 2 illustrates the factors’
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Table 2 Each factor’s contribution to the growth of health
expenditure in different scenarios
Drivers Scenario 1 (%) Medium
assumption
Scenario 2 (%)
Disease prevalence rate −0.370 −0.252 −0.312
Population growth 0.791 0.788 0.789
Population ageing 1.312 1.302 1.297
Excess health price inflation 1.343 1.339 1.342
Real expenditure per
prevalent case
8.514 8.414 8.473
Total 11.591 11.591 11.591
Zhai et al. BMC Health Services Research  (2017) 17:185 Page 7 of 9effect on the growth rate (11.59%) of health expenditure
during the research period in different scenarios. 8.41–
8.51% out of the overall growth of 11.59% was caused by
the changes of real expenditure per prevalent case,
followed by EHPI (1.339–1.343%) and population ageing
(1.30–1.31%). Population growth contributed 0.788–
0.791% of the growth, while changes in the disease
prevalence rate reduced the overall health expenditure
growth, contributing from −0.37 to −0.25% to growth.
Table 3 shows each factor’s contribution to the change
in health expenditure from 1993 to 2012 in the different
scenarios. Real expenditure per prevalent case contrib-
uted 72.59–73.45% of the change in health expenditure,
the prevalence rate contribution ranged from −3.19 to
−2.17%, EHPI contributed 11.55–11.59%, population
ageing contributed 11.19–11.32% and population growth
contributed 6.80–6.82%.
From the results we can see that the trend of the
numbers in Tables 2 and 3 is nonlinear. For example,
when we used the upper confidence bound of the
prevalence rate in the sensitivity analysis it did not
show a greater contribution to the changes in health
expenditure. This is because the changes in preva-
lence rate in 1993 and 2012 of the upper confidence
bound are not always greater than that of the lower
confidence bound or the mean prevalence rate. For
instance, during the research period, the upperTable 3 Each factor’s contribution to the change in health
expenditure in different scenarios
Drivers Scenario 1 (%) Medium
assumption
Scenario 2 (%)
Disease prevalence rate −3.19 −2.17 −2.69
Population growth 6.82 6.80 6.81
Population ageing 11.32 11.23 11.19
Excess health price inflation 11.59 11.55 11.58
Real expenditure per
prevalent case
73.45 72.59 73.10
Total 100.00 100.00 100.00confidence bound of the prevalence rate of population
aged 50–59 with endocrine, nutritional and metabolic
diseases increased by 3.50% (from 15.64 to 19.14%),
which is higher than the change of the mean preva-
lence rate of population aged 50–59 with this kind of
disease (3.48%, increased from 13.41 to 16.90%),
although less than the change of the lower confidence
bound of the prevalence rate of population aged 50–
59 with this kind of disease (3.55%, increased from
11.19 to 14.73%).
Discussion
Compared with regression based methods, Das Gupta’s
decomposition method can fully decompose the growth
of disease-specific health expenditure between two time
points into selected effecting factors, and with full
allocation of interaction effects. Major decomposition
results in this study from Das Gupta’s method are
consistent with views from empirical studies.
For example, empirical evidence suggests that the age
structure of the population has only a modest impact on
the growth of health expenditure [29]. Similarly, this study
showed that population ageing was not a significant driver
of health expenditure growth in China. In addition,
longevity gains will progressively postpone health expend-
iture from one age class to the next, reducing further the
impact of population ageing [30]. However, the proportion
of population aged 60+ in China is projected to be 25.4%
in 2030 even under the two-child policy implemented in
2016, therefore, proportion of the growth of health
expenditure in the future will increase due to population
ageing.
Expenditure per prevalent case was the main factor
that drove the growth of health expenditure over this
period. Growth in expenditure per prevalent case is in
turn driven by factors such as income growth, techno-
logical advances, health insurance changes, consumer
preferences and changes in service provision practices
by health providers. Further work could analyse the
exact role of these factors in driving growth in expend-
iture per prevalent case. Another driver of increases in
expenditure per prevalent case is providers’ profit seek-
ing behaviour. The government sets prices for simple
and non-invasive services well below cost, while setting
prices above cost for high-tech diagnostics and examina-
tions [31]. Furthermore, the government allows a 15%
profit margin on pharmaceuticals. This price schedule
has created perverse incentives for providers, who have
to generate 90% of their budget from revenue-
generation [21], which causes increases in charges per
outpatient visit and inpatient admission. During the
period 1993 to 2012, outpatient charges per capita
increased from 29.1 Yuan (US$ 3.5) to 80.2 Yuan (US$
12.7) and per capita inpatient charges increased from
Zhai et al. BMC Health Services Research  (2017) 17:185 Page 8 of 91216.4 Yuan (US$ 145.7) to 2992.3 Yuan (US$ 474.0) in
constant 1993 prices [32]. Additionally, patients tend to
utilise health services with higher price in higher level
hospitals in the past two decades. For example, the pro-
portion of total visits in township hospitals decreased
from 59.1% in 1993 to 28.8% in 2012, and proportion of
total discharges provided in township hospitals went
down from 48.7 to 26.1% during the same period [32],
due to rapid urbanisation and low provision capacity of
grass-root health facilities.
The other major driver was EHPI. The health care
sector has a higher proportion of high-skilled
workers than average, and salary levels for high-
skilled workers rise faster than for low-skilled
workers in the labour market [33]. In China, the
number of people with a junior college degree in-
creased from 5.6% in 2005 to 10.6% in 2012, while
among health personnel, the number increased from
46.3 to 64.3% during the same period [34]. Higher
health price inflation is not unique to China. For ex-
ample, EHPI in the United Kingdom was 1.6% per
year [33]. Health service pricing reform is one of the
main objectives of the new round of health system
reform being undertaken in China, with the aim to
adjust prices so they better reflect resource costs.
However, research has revealed that the regulated
health service price may actually undermine equitable
access to care [31].
The decrease in the prevalence rate of injuries and
poisoning, and infectious and parasitic diseases slo-
wed down the growth of health expenditure. That is
partly because a series of regulations and laws related
to safety in production and transport, occupational
injuries and poisoning have been issued by the gov-
ernment to prevent and control the prevalence of in-
jury [35]. Furthermore, China has made great
progress in infectious disease control. Through estab-
lishing a disease control and prevention system, pro-
moting vaccination and organising a patriotic health
campaign, China has successfully lowered the inci-
dence of infectious diseases and effectively controlled
most major infectious diseases [36]. On the other
hand, China now faces emerging challenges in the in-
creasing burden of some non-communicable diseases
(NCDs) and the rising prevalence of some risk
factors. NCDs are responsible for 77% of the loss in
healthy life and 85% of all deaths, a profile similar to
that of most Organisation for Economic Co-operation
and Development (OECD) countries [37]. High-risk
behaviours such as smoking, poor diets, sedentary
lifestyles and alcohol consumption, as well as environ-
mental factors such as air pollution, are powerful
forces behind the emergence of chronic illnesses in
China [38].Conclusion
In conclusion, we have decomposed the growth of health
expenditure over a 20 year period in China. We found
that expenditure per prevalent case was the major driver
of health expenditure growth, and the effect of economic
growth and technological progress may be absorbed in
the effect of expenditure per prevalent case. EHPI played
a secondary role, and demographic factors were a
small contributor to growth, while reductions in
disease prevalence rate slowed down the growth to
some extent. Moreover, we find that the growth of
health expenditure for neoplasms, and circulatory,
respiratory, endocrine, nutritional and metabolic and
digestive diseases over the period dramatically drove
the increase in health expenditure. Our results indi-
cate that population ageing played a more important
role in the growth of circulatory, neoplasms, and
endocrine, nutritional and metabolic, digestive and
musculoskeletal diseases expenditure than other
disease expenditures.
Our work highlights that reforms which constrain
growth in health expenditure per case of disease and
EHPI, especially for neoplasms and circulatory, respira-
tory, endocrine, nutritional and metabolic and digestive
diseases, are fundamental to the control of the rapid
growth of health expenditure in China. Enlarging the
service package of the Program for the Universal Cover-
age of Essential Public Health Services implemented
from 2009 may be a desirable option to further reduce
the disease prevalence rate. Strengthening the capacity
of health personnel in grass-roots facilities and establish-
ing an effective referral system can help to moderate the
rapid growth of expenditure per prevalent case and en-
sure that extra services are provided in areas where they
will achieve the greatest health gain. EHPI needs to be
controlled to ensure that extra resources result in extra
services rather than higher incomes for health providers.
Further research into region-specific drivers of health
expenditure growth will enable expenditure optimising
measures to be better targeted while at the same time
achieving equity goals.
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